Literature DB >> 15494311

SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival.

Jamie E Hoberg1, Fan Yeung, Marty W Mayo.   

Abstract

Understanding how signaling cascades stimulate chromatin-remodeling events through derepression is one of the foremost questions in the transcription field. Here, we demonstrate that NF-kappaB transcription requires IKKalpha to phosphorylate SMRT on chromatin, stimulating the exchange of corepressor for coactivator complexes. IKKalpha-induced phosphorylation coincides with a loss of chromatin-associated SMRT and HDAC3 and with nuclear export of the SMRT corepressor, events required for expression of the NF-kappaB-regulated cIAP-2 and IL-8 genes. Although SMRT derepression corresponds with the recruitment of TBL1/TBLR1, this complex alone is insufficient to relieve repression. Using a nonphosphorylatable SMRT protein, we demonstrate that IKKalpha-induced phosphorylation is required to recruit 14-3-3epsilon and Ubc5 for SMRT derepression. Failure of IKKalpha to stimulate the removal of SMRT from chromatin inhibits the recruitment of NF-kappaB to promoters, blocking transcription and sensitizing cells to apoptosis. Our work provides evidence that IKKalpha orchestrates SMRT derepression, a prerequisite for NF-kappaB transcription and survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494311     DOI: 10.1016/j.molcel.2004.10.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  104 in total

1.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

2.  Transducin β-like protein 1 recruits nuclear factor κB to the target gene promoter for transcriptional activation.

Authors:  Sivakumar Ramadoss; Jiong Li; Xiangming Ding; Khalid Al Hezaimi; Cun-Yu Wang
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

3.  Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.

Authors:  Katie Schumm; Sonia Rocha; Jorge Caamano; Neil D Perkins
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

Review 4.  PPARs and molecular mechanisms of transrepression.

Authors:  Mercedes Ricote; Christopher K Glass
Journal:  Biochim Biophys Acta       Date:  2007-03-12

5.  Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function.

Authors:  Zhanguo Gao; Qing He; Bailu Peng; Paul J Chiao; Jianping Ye
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

Review 6.  COMMD proteins and the control of the NF kappa B pathway.

Authors:  Gabriel N Maine; Ezra Burstein
Journal:  Cell Cycle       Date:  2007-03-07       Impact factor: 4.534

7.  Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.

Authors:  Serena Ghisletti; Wendy Huang; Kristen Jepsen; Chris Benner; Gary Hardiman; Michael G Rosenfeld; Christopher K Glass
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

8.  Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.

Authors:  Zong-Yang Li; Qing-Zhong Li; Lei Chen; Bao-Dong Chen; Bo Wang; Xie-Jun Zhang; Wei-Ping Li
Journal:  Neurochem Res       Date:  2016-09-08       Impact factor: 3.996

Review 9.  How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?

Authors:  Bärbel Schröfelbauer; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 10.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.